Johanne Kaplan, Chief Development Officer at ProMIS Neurosciences, bought PMN on Aug 5, 2026
Data as of Oct 16
▲ BUY$30.3K2,280 shares at $13.30Johanne Kaplan Chief Development OfficerPMN ProMIS Neurosciences Inc.
- Traded
- Aug 5, 2026
- Disclosed
- Aug 7, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PMN since disclosure
−44.6%
Similar stocks (XLV) since disclosure
+6.7%
XLV — its sector index fund
Change in closing price from Aug 7, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.